Airrosti Executive and Leadership Team

Kelly Green, the Chief Executive Officer at Airrosti, directs the overarching strategic vision for this musculoskeletal healthcare organization. Green architects long-term growth initiatives while ensuring the delivery of high-quality, outcome-based soft tissue care across the United States. By aligning clinical excellence with operational efficiency, the Chief Executive Officer maintains the company's market position as a leader in non-invasive rehabilitation. Kelly Green monitors performance metrics to guarantee that patient recovery goals remain the primary focus of every department. Through consistent leadership, the Chief Executive Officer fosters a culture of innovation that supports the expansion of specialized joint care services. This executive role involves constant collaboration with the board to refine business models and enhance the accessibility of care. Ultimately, Green secures the financial and operational health of the organization while driving the mission to provide rapid, effective relief for patients suffering from chronic or acute musculoskeletal conditions.

Emily McKay, the Chief Financial Officer at Airrosti, manages the fiscal health and capital allocation strategies for this rehabilitation healthcare group. McKay oversees budgeting, financial reporting, and revenue cycle management to ensure the sustainability of musculoskeletal care delivery. By analyzing market trends and operational costs, the Chief Financial Officer optimizes resource distribution across regional clinics. Emily McKay directs financial planning efforts that support the scaling of soft tissue treatment programs. This leadership role requires close coordination with other executives to align fiscal objectives with clinical outcomes. Through rigorous oversight of financial systems, the Chief Financial Officer mitigates risk and identifies opportunities for reinvestment in patient-centered technology. McKay maintains transparency in all fiscal matters, providing the necessary data to support strategic decision-making. Ultimately, the Chief Financial Officer ensures that the organization possesses the resources required to maintain high standards of care while achieving long-term profitability and growth.

X - Zubair Faiz, the Chief Information Officer at Airrosti, architects the digital infrastructure and data security frameworks necessary for modern musculoskeletal healthcare. Faiz directs the implementation of health information systems that track patient recovery outcomes and streamline clinical workflows. By leveraging advanced data analytics, the Chief Information Officer enhances the precision of soft tissue and joint care delivery. X - Zubair Faiz oversees the integration of secure communication platforms that connect patients with providers across the national network. This leadership role involves protecting sensitive health information while ensuring seamless access to digital tools for the entire clinical staff. Through the modernization of internal systems, the Chief Information Officer drives operational efficiency and supports the company's commitment to evidence-based rehabilitation. Faiz maintains a robust technological environment that adapts to the evolving needs of the healthcare industry. Ultimately, the Chief Information Officer secures the digital foundation that enables the organization to deliver superior patient results.

Jason Garrett, the Chief Medical Officer at Airrosti, defines the clinical standards and treatment protocols for this musculoskeletal rehabilitation group. Garrett directs the training and performance of providers to ensure consistent, high-quality soft tissue and joint care. By monitoring clinical outcomes, the Chief Medical Officer refines the methodologies used to treat patients suffering from chronic pain or injury. Jason Garrett collaborates with the executive team to integrate medical advancements into the company's core service offerings. This leadership role involves maintaining compliance with healthcare regulations while fostering a culture of continuous improvement among the clinical staff. Through the oversight of medical quality, the Chief Medical Officer ensures that every patient receives effective, non-invasive care tailored to specific recovery needs. Garrett drives the development of new clinical initiatives that expand the reach of the organization's specialized services. Ultimately, the Chief Medical Officer guarantees that the company remains at the forefront of musculoskeletal health.